Gerresheimer AG

Equities

GXI

DE000A0LD6E6

Medical Equipment, Supplies & Distribution

Market Closed - Xetra Other stock markets 11:35:24 2024-04-29 am EDT			After market 03:52:12 pm
100.4 ^EUR	-0.10%		100.6	+0.15%

12:00am	Gerresheimer AG acquired minority stake in RxCap Inc.	CI
Apr. 22	GERRESHEIMER AG : Buy rating from Barclays	ZD

Gerresheimer AG Provides Earnings Guidance for the Year 2024 and 2025

April 11, 2024 at 01:20 am EDT

Gerresheimer AG provided earnings guidance for the year 2024 and 2025. For the year 2024, the company expects revenue growth of 5% to 10%.

For the year 2025, the company expects revenue growth of 10% to 15%.

Latest news about Gerresheimer AG

Gerresheimer AG acquired minority stake in RxCap Inc.	2024-04-28	CI
GERRESHEIMER AG : Buy rating from Barclays	Apr. 22	ZD
GERRESHEIMER AG : Jefferies remains its Buy rating	Apr. 22	ZD
Gerresheimer in demand after Stifel recommendation	Apr. 17	DP
GERRESHEIMER AG : Deutsche Bank remains its Buy rating	Apr. 15	ZD
GERRESHEIMER AG : Berenberg gives a Buy rating	Apr. 15	ZD
GERRESHEIMER AG : Deutsche Bank reiterates its Buy rating	Apr. 12	ZD
GERRESHEIMER AG : Buy rating from JP Morgan	Apr. 12	ZD
Gerresheimer shares down on outlook, but key contracts confirmed	Apr. 11	RE
Barclays upgrades Gerresheimer to 'Overweight' - Target 125 euros	Apr. 11	DP
GERRESHEIMER AG : Barclays reiterates its Buy rating	Apr. 11	ZD
Gerresheimer continues to focus on recovery from the summer - share price falls	Apr. 11	DP
Gerresheimer very weak - Certain uncertainties about outlook	Apr. 11	DP
Gerresheimer supplies 'key players' in GLP-1 drugs market, CEO says	Apr. 11	RE
Transcript : Gerresheimer AG, Q1 2024 Earnings Call, Apr 11, 2024	Apr. 11
GERRESHEIMER AG : Gets a Buy rating from Jefferies	Apr. 11	ZD
GERRESHEIMER AG : JP Morgan maintains a Buy rating	Apr. 11	ZD
Gerresheimer expects sales boost from burgeoning obesity drugs sector	Apr. 11	RE
Partially lower pharmaceutical demand slows down Gerresheimer - outlook confirmed	Apr. 11	DP
Gerresheimer AG Provides Earnings Guidance for the Year 2024 and 2025	Apr. 11	CI
Gerresheimer AG Reports Earnings Results for the First Quarter Ended February 29, 2024	Apr. 10	CI
GERRESHEIMER AG : Receives a Buy rating from JP Morgan	Apr. 08	ZD
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
GERRESHEIMER AG : Deutsche Bank maintains a Buy rating	Mar. 27	ZD
GERRESHEIMER AG : Barclays keeps its Buy rating	Mar. 27	ZD

Chart Gerresheimer AG

Duration

Period

More charts

Company Profile

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-04 - RDD Europe Conference

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Ratings for Gerresheimer AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

100.4 EUR

Average target price

132.9 EUR

Spread / Average Target

+32.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GERRESHEIMER AG	+6.41%	3.71B
ABBOTT LABORATORIES	-2.54%	187B
MEDTRONIC PLC	-1.85%	106B
BECTON, DICKINSON AND COMPANY	-4.26%	66.9B
DEXCOM, INC.	+1.39%	49.45B
CENCORA, INC.	+16.82%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution